Keisuke Imamura
18Patents
2h-index
50Co-inventors
53Inventor score
Filing activity: Jun 22, 2011 → Mar 13, 2025
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10428023B2 | Heterocyclic compound and use thereof | Chemistry; Metallurgy | 15 | Active |
| US10584097B2 | Heterocyclic compound and use thereof | Chemistry; Metallurgy | 10 | Active |
| US10577382B2 | Fused heterocyclic compound | Human Necessities | 2 | Active |
| US8563575B2 | Fused heterocyclic compounds | Chemistry; Metallurgy | 2 | Active |
| US11440883B2 | Heterocyclic compound and use thereof | Chemistry; Metallurgy | 1 | Active |
| US8940758B2 | Fused heterocyclic compounds | Chemistry; Metallurgy | 1 | Active |
| US11319286B2 | Heterocyclic compound and application thereof | Chemistry; Metallurgy | 1 | Active |
| US9226921B2 | Fused heterocyclic compounds as phosphodiesterases (PDES) inhibitors | Chemistry; Metallurgy | 1 | Active |
| US8846713B2 | Fused heterocyclic compounds as phosphodiesterases (PDEs) inhibitors | Chemistry; Metallurgy | 1 | Active |
| US11655241B2 | Heterocyclic compound and use thereof | Chemistry; Metallurgy | 1 | Active |
| US10981934B2 | Fused heterocyclic compound | Human Necessities | 1 | Active |
| US9029388B2 | Condensed heterocyclic compound | Chemistry; Metallurgy | 1 | Active |
| US12404237B2 | Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1′-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivatives | Chemistry; Metallurgy | 0 | Active |
| US11390634B2 | Fused heterocyclic compound | Human Necessities | 0 | Active |
| US12415782B2 | Heterocyclic compound and use thereof | Chemistry; Metallurgy | 0 | Active |
| US12421188B2 | Heterocyclic compound and use thereof | Chemistry; Metallurgy | 0 | Active |
| US12091410B2 | Heterocyclic compound | Chemistry; Metallurgy | 0 | Active |
| US12071434B2 | Heterocyclic compound | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.